Post audit review: Merck Sharp & Dohme Limited

Oversight record (audit, advice, assessment or regulatory action) from NHS England data sharing audits. Evidence status: source reported.

Organisation

Merck Sharp & Dohme Limited

Published

2023-02-01

Source reference

2023-post-audit-review-nweh

Jurisdiction

England

Licence

Open Government Licence v3.0 (NHS England)

Post audit review of Merck Sharp & Dohme Limited by NHS England · Audit between 4 and 8 October 2021 · Risk assigned: Low · 4 agreement nonconformities, 3 observations, 9 opportunities for improvement, 3 points for follow up · Agreements DARS-NIC-290527-P5C0Y, DARS-NIC-290527-P5COY · Based on the evidence provided by the 3 organisations, the Audit Team has found that MFT and NWEH have not suitably addressed the findings.

Source: https://digital.nhs.uk/services/data-access-request-service-dars/data-sharing-audits/2023/post-audit-review-nweh. Captured 2026-10-30.

Limitations: An audit report as NHS England publishes it. Findings are against a sample of the organisation's activities and the contracts in force at the time; an audit with no findings recorded here may still have had some, as older reports state them in tables or by highlighting that are not read. Publication is given to the month only. The report's text is not stored; follow the link to read it.